Professor, Medicine, University of Arizona College of Medicine
Endocrinology
Dr. William C. Duckworth, MD
|
|
Give Review
Doctor William C. Duckworth, MD practices Endocrinology. He studied medicine at University of Tennessee College of Medicine. William Duckworth is a published MD. He published 99 publications, including: 'Effect of antecedent hormone administration on lipolysis in the perifused isolated fat cell.'
Publications
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy.
- Association of PAI-1 and Fibrinogen with Diabetic Retinopathy in the Veterans Affairs Diabetes Trial (VADT).
- Undoing Flexner: the beginning of the end of academic medicine in America.
- Insulin metabolism in human adipocytes from subcutaneous and visceral depots.
- Retinoblastoma protein co-purifies with proteasomal insulin-degrading enzyme: implications for cell proliferation control.
- Pioglitazone reduces inflammatory responses of human adipocytes to factors secreted by monocytes/macrophages.
- Blood glucose monitoring is associated with better glycemic control in type 2 diabetes: a database study.
- Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencing.
- Adoption of a new technology in a Veterans Affairs national formulary system with local implementation: the insulin glargine example.
- Reliability and validity of the DCP among hispanic veterans.
- Hypoglycemia in stable, insulin-treated veterans with type 2 diabetes: a prospective study of 1662 episodes.
- Food frequency questionnaire results correlate with metabolic control in insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study.
- Reduced action of insulin glargine on protein and lipid metabolism: possible relationship to cellular hormone metabolism.
- A probabilistic model for predicting hypoglycemia in type 2 diabetes mellitus: The Diabetes Outcomes in Veterans Study (DOVES).
- Biological activity of a fragment of insulin.
- Insulin-degrading activity in wound fluid.
- An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures.
- Risk factor management in stable, insulin-treated patients with Type 2 diabetes: the Diabetes Outcomes in Veterans Study.
- Inhibition of proteasome activity by selected amino acids.
- Beneficial effects of a glyburide/metformin combination preparation in type 2 diabetes mellitus.
- Endopeptidase from rat liver membranes, which generates miniglucagon from glucagon.
- Insulin therapy prevents spontaneous recovery from streptozotocin-induced diabetes in Syrian hamsters. An autoradiographic and immunohistochemical study.
- Veterans Affairs diabetes trial--corrections.
- Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D).
- Improvements in glycemic control in type 2 diabetes patients switched from sulfonylurea coadministered with metformin to glyburide-metformin tablets.
- Comparison of dilated fundus examinations with seven-field stereo fundus photographs in the Veterans Affairs Diabetes Trial.
- Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis.
- Glucose control and vascular complications in veterans with type 2 diabetes.
- Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial.
- Preliminary report: hepatic fat and inflammation in type 2 diabetes mellitus.
- Proliferative diabetic retinopathy in type 2 diabetes is related to coronary artery calcium in the Veterans Affairs Diabetes Trial (VADT).
- Ethnicity, race, and clinically significant macular edema in the Veterans Affairs Diabetes Trial (VADT).
- The association between metabolic control and prevalent macrovascular disease in Type 2 diabetes: the VA Cooperative Study in diabetes.
- Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies.
- Ethnicity, race, and baseline retinopathy correlates in the veterans affairs diabetes trial.
- Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.
- Evaluating once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes : the diabetes outcomes in ve...
- Advances in the treatment of diabetes-insulin analogues.
- Accelerated insulin degradation: an alternate mechanism for insulin resistance.
- Recombinant DNA technology in the treatment of diabetes: insulin analogs.
- Hyperglycemia and cardiovascular disease.
- Characterization of the inhibition of protein degradation by insulin in L6 cells.
- Insulin inhibits peroxisomal fatty acid oxidation in isolated rat hepatocytes.
- Glucose control and cardiovascular complications: the VA Diabetes Trial.
- Insulin pumps and glucose regulation.
- Insulin and analogue effects on protein degradation in different cell types. Dissociation between binding and activity.
- Degradation of amylin by insulin-degrading enzyme.
- Insulin inhibits the ubiquitin-dependent degrading activity of the 26S proteasome.
- Genetically engineered insulin analogs: diabetes in the new millenium.
- Hepatitis A-induced diabetes mellitus, acute renal failure, and liver failure.
- Differences in the cellular processing of AspB10 human insulin compared with human insulin and LysB28ProB29 human insulin.
- Surgical experience with implantable insulin pumps. Department of Veterans Affairs Implantable Insulin Pump Study Group.
- Insulin degradation: progress and potential.
- The Veterans Affairs Implantable Insulin Pump Study: effect on cardiovascular risk factors.
- Regulation of multicatalytic enzyme activity by insulin and the insulin-degrading enzyme.
- Insulin acts intracellularly on proteasomes through insulin-degrading enzyme.
- HLA-D types and serum IgG responses to Capnocytophaga in diabetes and periodontitis.
- Two pathways for insulin metabolism in adipocytes.
- Tumor necrosis factor and insulin resistance: specificity of sequence accounts of inhibition of insulin action.
- Insulin inhibition of proteasome activity in intact cells.
- Identification of the cleavage sites of transforming growth factor alpha by insulin-degrading enzymes.
- Intraendosomal degradation of transforming growth factor alpha.
- The significance of intracellular insulin to insulin action.
- Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex.
- The relationship between insulin and vanadium metabolism in insulin target tissues.
- Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable ...
- Processing of 125I-insulin by polarized cultured kidney cells.
- Recipient selection and evaluation for vascularized pancreas transplantation.
- Alteration of rat hepatic insulin metabolism by glyburide and glipizide.
- Cellular and endosomal insulin degradation.
- Combined pancreas-kidney transplantation: preliminary results and metabolic effects.
- Intensive management of type II diabetes.
- Degradation of intraendosomal insulin by insulin-degrading enzyme without acidification.
- Combined pancreas--kidney transplantation in Nebraska.
- Identification of the metal associated with the insulin degrading enzyme.
- Lipid status after pancreas-kidney transplantation.
- Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin.
- Effects of sequence and timing of hormonal additions on adipose tissue: activation of low-Km cyclic adenosine monophosphate phosphodiesterase.
- Why intraperitoneal delivery of insulin with implantable pumps in NIDDM?
- The Department of Veterans Affairs Implanted Insulin Pump Study.
- Sites of cleavage of glucagon by insulin-glucagon protease.
- The effect of somatostatin on platelet aggregation.
- Effect of antecedent hormone administration on lipolysis in the perifused isolated fat cell.
- The effect of age on plasma proinsulin-like material after oral glucose.
- Inhibition of insulin degradation by nonsuppressible insulin-like activity.
- Perifusion of isolated rat adipose cells. Modulation of lipolysis by adenosine.
- A continuous automated assay of lipolysis during perifusion of isolated fat cells.
- Insulin binding and degradation by muscles from streptozotocin-diabetic rats.
- Insulin degradation by liver cell membranes.
- The effect of age on insulin-degrading activity in rat tissue.
- Simulated hyperglycemic hyperosmolar syndrome. Impaired insulin and epinephrine effects upon lipolysis in the isolated rat fat cell.
- Effect of prolonged uremia on insulin metabolism by isolated liver and muscle.
- Abnormal pancreatic endocrine function in Reye''s syndrome survivors and their relatives: a preliminary report.
- Initial site of insulin cleavage by insulin protease.
- Proteolytic degradation of insulin and glucagon.
- Corticosteroid-responsive skeletal muscle disease associated with partial carnitine deficiency: studies of liver and metabolic alterations.
- Human islet cell adenoma: metabolic analysis of the patient and of tumor cells in monolayer culture.
- Insulin resistance caused by massive degradation of subcutaneous insulin.
Doctors Specialties
- Endocrinology
Accepted Insurances
Education
-
University of Tennessee -
University of Tennessee College of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. James V. Felicetta, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lester A. Epstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rohit Dwivedi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Unen D. Hsu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dineshkumar H. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marie S. Thearle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elena V. Plummer, MD
This Doctor is OpenDoctor Recommended.
|